181 related articles for article (PubMed ID: 26889025)
1. Novel Feline Leukemia Virus Interference Group Based on the env Gene.
Miyake A; Watanabe S; Hiratsuka T; Ito J; Ngo MH; Makundi I; Kawasaki J; Endo Y; Tsujimoto H; Nishigaki K
J Virol; 2016 May; 90(9):4832-4837. PubMed ID: 26889025
[TBL] [Abstract][Full Text] [Related]
2. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.
Stewart H; Adema KW; McMonagle EL; Hosie MJ; Willett BJ
Retrovirology; 2012 May; 9():48. PubMed ID: 22650160
[TBL] [Abstract][Full Text] [Related]
4. Host cell range of T-lymphotropic feline leukemia virus in vitro.
Shojima T; Nakata R; Miyazawa T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
[TBL] [Abstract][Full Text] [Related]
5. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.
Shalev Z; Duffy SP; Adema KW; Prasad R; Hussain N; Willett BJ; Tailor CS
J Virol; 2009 Jul; 83(13):6706-16. PubMed ID: 19369334
[TBL] [Abstract][Full Text] [Related]
6. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
[TBL] [Abstract][Full Text] [Related]
7. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.
Kristal BS; Reinhart TA; Hoover EA; Mullins JI
J Virol; 1993 Jul; 67(7):4142-53. PubMed ID: 8389921
[TBL] [Abstract][Full Text] [Related]
8. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
[TBL] [Abstract][Full Text] [Related]
9. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
10. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
11. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.
Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P
J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228
[TBL] [Abstract][Full Text] [Related]
12. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
Moser M; Burns CC; Boomer S; Overbaugh J
Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
[TBL] [Abstract][Full Text] [Related]
13. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
[TBL] [Abstract][Full Text] [Related]
14. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
Ito J; Baba T; Kawasaki J; Nishigaki K
J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
[TBL] [Abstract][Full Text] [Related]
15. Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.
Ito J; Watanabe S; Hiratsuka T; Kuse K; Odahara Y; Ochi H; Kawamura M; Nishigaki K
J Virol; 2013 Nov; 87(22):12029-40. PubMed ID: 23966402
[TBL] [Abstract][Full Text] [Related]
16. Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.
Mendoza R; Miller AD; Overbaugh J
J Virol; 2013 Mar; 87(5):2412-9. PubMed ID: 23269813
[TBL] [Abstract][Full Text] [Related]
17. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
[TBL] [Abstract][Full Text] [Related]
18. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
[TBL] [Abstract][Full Text] [Related]
19. Identification of Copper Transporter 1 as a Receptor for Feline Endogenous Retrovirus ERV-DC14.
Tury S; Giovannini D; Ivanova S; Touhami J; Courgnaud V; Battini JL
J Virol; 2022 Jun; 96(12):e0022922. PubMed ID: 35652657
[TBL] [Abstract][Full Text] [Related]
20. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
